.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Accenture
Covington
Daiichi Sankyo
US Department of Justice
Deloitte
Cerilliant
UBS
Queensland Health
Teva
Cantor Fitzgerald

Generated: January 20, 2018

DrugPatentWatch Database Preview

Patents Expiring in December 2023

« Back to Dashboard

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Becton Dickinson CoCHLORAPREP WITH TINTchlorhexidine gluconate; isopropyl alcoholSPONGE;TOPICAL020832-002May 3, 2005OTCYesYes➤ Subscribe➤ SubscribeY
Becton Dickinson CoCHLORAPREP ONE-STEPchlorhexidine gluconate; isopropyl alcoholSPONGE;TOPICAL020832-006Nov 21, 2006OTCYesYes➤ Subscribe➤ SubscribeY
Smithkline BeechamCOREG CRcarvedilol phosphateCAPSULE, EXTENDED RELEASE;ORAL022012-004Oct 20, 2006ABRXYesNo➤ Subscribe➤ SubscribeY
Smithkline BeechamCOREG CRcarvedilol phosphateCAPSULE, EXTENDED RELEASE;ORAL022012-003Oct 20, 2006ABRXYesYes➤ Subscribe➤ SubscribeY
Smithkline BeechamCOREG CRcarvedilol phosphateCAPSULE, EXTENDED RELEASE;ORAL022012-002Oct 20, 2006ABRXYesNo➤ Subscribe➤ SubscribeY
Smithkline BeechamCOREG CRcarvedilol phosphateCAPSULE, EXTENDED RELEASE;ORAL022012-001Oct 20, 2006ABRXYesNo➤ Subscribe➤ SubscribeY
OtsukaABILIFYaripiprazoleSOLUTION;ORAL021713-001Dec 10, 2004DISCNYesNo➤ Subscribe➤ SubscribeADJUNCTIVE TREATMENT OF MAJOR DEPRESSIVE DISORDER (MDD)
OtsukaABILIFYaripiprazoleTABLET;ORAL021436-004Nov 15, 2002ABRXYesNo➤ Subscribe➤ SubscribeADJUNCTIVE TREATMENT OF MAJOR DEPRESSIVE DISORDER (MDD)
OtsukaABILIFYaripiprazoleTABLET;ORAL021436-003Nov 15, 2002ABRXYesNo➤ Subscribe➤ SubscribeADJUNCTIVE TREATMENT OF MAJOR DEPRESSIVE DISORDER (MDD)
OtsukaABILIFYaripiprazoleTABLET;ORAL021436-002Nov 15, 2002ABRXYesNo➤ Subscribe➤ SubscribeADJUNCTIVE TREATMENT OF MAJOR DEPRESSIVE DISORDER (MDD)
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Novartis
Farmers Insurance
McKinsey
Chinese Patent Office
US Department of Justice
Johnson and Johnson
Fish and Richardson
Medtronic
Moodys
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot